These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29748871)

  • 1. An Introduction to "Recent Trends in the Biotechnology Industry: Development and Manufacturing of Recombinant Antibodies and Proteins".
    Pohlscheidt M; Kiss R; Gottschalk U
    Adv Biochem Eng Biotechnol; 2018; 165():1-8. PubMed ID: 29748871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopharmaceuticals in China.
    Hu X; Ma Q; Zhang S
    Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growing pains for biopharmaceuticals.
    Ashton G
    Nat Biotechnol; 2001 Apr; 19(4):307-11. PubMed ID: 11283578
    [No Abstract]   [Full Text] [Related]  

  • 4. The biopharmaceutical industry in China: history and future perspectives.
    Gao K; Wang J
    Front Med; 2012 Jun; 6(2):101-11. PubMed ID: 22544299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical biotechnology products approved within the European Union.
    Walsh G
    Eur J Pharm Biopharm; 2003 Jan; 55(1):3-10. PubMed ID: 12551698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies as innovative therapeutics.
    Reichert JM
    Curr Pharm Biotechnol; 2008 Dec; 9(6):423-30. PubMed ID: 19075682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic antibodies market to 2008.
    Pavlou AK; Belsey MJ
    Eur J Pharm Biopharm; 2005 Apr; 59(3):389-96. PubMed ID: 15760719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosimilars advancements: Moving on to the future.
    Tsuruta LR; Lopes dos Santos M; Moro AM
    Biotechnol Prog; 2015; 31(5):1139-49. PubMed ID: 25708573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharma Success in Product Development—Does Biotechnology Change the Paradigm in Product Development and Attrition.
    Evens RP
    AAPS J; 2016 Jan; 18(1):281-5. PubMed ID: 26475480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next Generation Biopharmaceuticals: Product Development.
    Mathaes R; Mahler HC
    Adv Biochem Eng Biotechnol; 2018; 165():253-276. PubMed ID: 29637223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The state of biopharmaceutical manufacturing.
    Molowa DT; Mazanet R
    Biotechnol Annu Rev; 2003; 9():285-302. PubMed ID: 14650933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative updating of approved biopharmaceuticals.
    Redwan el-RM
    Hum Antibodies; 2007; 16(3-4):137-58. PubMed ID: 18334749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in capacity utilization for therapeutic monoclonal antibody production.
    Langer ES
    MAbs; 2009; 1(2):151-6. PubMed ID: 20061821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid and disposable facilities for manufacturing of biopharmaceuticals: pros and cons.
    Ravisé A; Cameau E; De Abreu G; Pralong A
    Adv Biochem Eng Biotechnol; 2009; 115():185-219. PubMed ID: 19623478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceutical benchmarks 2018.
    Walsh G
    Nat Biotechnol; 2018 Dec; 36(12):1136-1145. PubMed ID: 30520869
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic monoclonal antibodies and derivatives: Historical perspectives and future directions.
    Rodgers KR; Chou RC
    Biotechnol Adv; 2016 Nov; 34(6):1149-1158. PubMed ID: 27460206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of therapeutic antibodies for the treatment of diseases.
    Lu RM; Hwang YC; Liu IJ; Lee CC; Tsai HZ; Li HJ; Wu HC
    J Biomed Sci; 2020 Jan; 27(1):1. PubMed ID: 31894001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland.
    Beck A; Wurch T; Reichert JM
    MAbs; 2011; 3(2):111-32. PubMed ID: 21441785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Russia through the prism of the world biopharmaceutical market.
    Bairamashvili DI; Rabinovich ML
    Biotechnol J; 2007 Jul; 2(7):801-17. PubMed ID: 17615600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifting Paradigms Revisited: Biotechnology and the Pharmaceutical Sciences.
    Crommelin DJA; Mastrobattista E; Hawe A; Hoogendoorn KH; Jiskoot W
    J Pharm Sci; 2020 Jan; 109(1):30-43. PubMed ID: 31449815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.